ArticleBMC infectious diseases2025
Epidemiological and clinical characteristics of West Nile virus infections in Istanbul, Türkiye: a population-based cohort study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spatiotemporal and Demographic Patterns of West Nile Neuroinvasive Disease in Vojvodina, Serbia, 2012-2025.Viruses · 2026Article
- Operationalizing the One Health approach in a conflict-affected setting: A scientometric review of policy foundations, systemic gaps, and future pathways in Ukraine.Veterinary world · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWest Nile virus (WNV) infection is a mosquito-borne infection that is usually asymptomatic but can also cause serious neurological diseases. This study aimed to determine the incidence and seasonal distribution of WNV infections in Istanbul, Turkiye, as well as risk factors for neuroinvasive disease and mortality.
methodsA population-based cohort study was conducted using surveillance data collected by the Health Directorate of Istanbul between 2010 and 2024. Cases meeting the national and EU case definitions for confirmed or probable WNV infection were included. Clinical, demographic, laboratory data, and outcomes were extracted from medical records. Relative risks (RR) and 95% confidence intervals (CI) were calculated using univariate analyses and log binomial regression to identify risk factors for neuroinvasive disease and mortality.
resultsA total of 159 reported WNV cases were included in the study, with incidence rates of 0.53 and 0.48 per 100,000 person-years calculated for the 2019 and 2024 outbreaks, respectively. All infections were reported between June and October. The mean patient age was 52.9 years; 65.4% were male. West Nile neuroinvasive disease (WNND) was diagnosed in 50.9% of cases, with encephalitis as the most common manifestation. The overall case fatality rate was 5.7% in all case, and 9.8% among WNND cases. Age was identified as an independent risk factor for WNND (RR
conclusionsThis study highlights the epidemiological and clinical characteristics of WNV infections over a 15-year period in Istanbul, Turkiye, identifying two major outbreaks in 2019 and 2024, with seasonal peaks in summer and early fall. The findings highlight the importance of increased clinical awareness and the inclusion of WNV in the differential diagnosis of encephalitic presentations, particularly in elderly patients during periods of high transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.